查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1927385

自膨式血管支架市场：依材质、设计、手术、应用、最终用户和适应症划分－2026-2032年全球预测

Self-Expanding Vascular Stent Market by Material, Design, Procedure Type, Application, End User, Indication - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

自膨式血管支架市场预计到 2025 年将达到 35.5 亿美元，到 2026 年将成长到 39.1 亿美元，到 2032 年将达到 69.7 亿美元，年复合成长率为 10.09%。

关键市场统计数据
基准年 2025 35.5亿美元
预计年份：2026年 39.1亿美元
预测年份 2032 69.7亿美元
复合年增长率 (%) 10.09%

本文提供了一个简洁的自动扩张型支架技术临床和商业性框架，将器械性能置于现代介入实践和相关人员期望的背景下进行分析。

在材料科学进步和临床实践不断发展的推动下，自膨式血管支架已成为治疗复杂血管疾病的关键器械。这些器械利用形状记忆合金和创新聚合物涂层，可在提供即时血管支撑的同时，适应复杂的血管解剖结构和不同的血管直径。对于需要动态调节径向力的解剖结构，以及需要在植入精度和长期血管癒合之间取得平衡的情况，临床医生越来越倾向于选择自膨式支架。因此，器械开发商和医疗系统正在调整产品规格、供应链和手术通讯协定，以更好地体现这些植入独特的机械和生物学特性。

技术创新、流程变革和监管要求的整合如何重塑自膨式血管支架的临床应用和竞争定位

由于技术创新、手术流程的演变以及医疗体系优先事项的共同作用，自膨式血管支架的市场格局正在经历变革性变化。合金工程和聚合物科学的进步使得器械具有更优异的贴合性和可控的径向强度，这正在影响手术方案的选择和术后管理。同时，混合手术和影像引导手术的兴起，正在拓展自膨式器械的应用范围，使其能够应用于传统上难以处理的解剖区域，例如复杂的周边血管和神经血管区域。这些发展正在重塑临床路径，并促使导管检查室和手术中心製定新的培训计划和调整库存。

评估2025年关税趋势对植入式血管器械的采购、製造地和供应连续性的营运和策略影响

2025年的关税措施和贸易政策调整增加了医疗设备（包括自膨式血管支架）全球供应链的复杂性。依赖跨境采购原料合金、特殊聚合物和精密製造设备的製造商面临成本重新评估和物流调整。进口关税的提高和合规查核点的增加加重了供应链团队的行政负担，促使一些公司考虑将关键生产过程迁回国内或实现区域供应商多元化。这些策略性供应链因应措施优先考虑供应的连续性、可追溯性和对不断变化的关税制度的合规性。

对材料科学、临床应用、设备结构和医疗环境进行多层次分析，可提供细分见解，从而指导优先产品选择和商业化策略。

细緻的細項分析揭示了临床需求、材料科学和医疗服务环境之间的交集，从而塑造了产品策略和商业性重点。根据材料，器械可分为钴铬合金、镍钛合金、聚合物和不銹钢结构，每种材料在径向强度、抗疲劳性和影像伪影方面各有优劣，影响临床选择。根据应用领域，目标解剖区域涵盖冠状动脉、神经血管和周边血管。冠状动脉领域进一步涵盖分叉病变、慢性完全阻塞和支架内血管再阻塞的治疗，而神经血管领域则针对动脉瘤治疗和中风预防。这显示解剖结构的复杂性决定了器械的设计和传输特性。根据设计，支架可分为裸金属支架、涂层支架和药物释放型支架，每种设计都会影响临床结果、抗凝血策略和长期血管重塑。

区域战略考量旨在协调美洲、欧洲、中东和非洲以及亚太地区不同的法规环境、临床实践和采购趋势。

区域趋势对开发商和医疗系统的策略重点有显着影响。在美洲，微创手术的快速普及和完善的报销机制推动了对兼具手术效率和持续疗效的医疗设备的需求。医疗系统在采购决策中强调疗效比较和持续的临床数据，而大型城市医院的卓越医疗中心则率先采用先进的设计。在欧洲、中东和非洲地区（EMEA），监管碎片化和报销政策不平衡导致了不同的应用模式。为了在多元化的医疗市场站稳脚跟，製造商必须在有针对性的临床试验策略、区域性证据产生和客製化定价模式之间取得平衡。该地区部分市场对成本高度敏感，而有些市场则拥有成熟的医疗服务体系，对高性能医疗器材有着迫切的需求。

透过结合临床证据产生、生产灵活性和许可授权的策略竞争优势，在植入式血管器械领域建立可持续的差异化优势。

自动扩张型支架领域的竞争格局取决于临床证据的深度、产品组合的广度以及生产和监管能力的灵活性。领导者将迭代式器材设计与完善的上市后监测相结合，形成回馈循环，从而加速器材优化并支援差异化的临床应用。与学术机构和大型临床试验中心建立策略联盟，能够为新适应症和手术流程改进提供培养箱；而与契约製造和物流专家的合作，则有助于在不损害品质系统的前提下实现地域扩张。与合金、涂层和输送机制相关的智慧财产权是核心资产，保护并选择性地授权这些技术的企业能够在控制研发风险的同时，拓展收入来源。

为协调临床证据产生、稳健的生产製造和以临床医生为中心的商业化，以加速产品应用并维持价值，提出切实可行的跨职能建议。

产业领导者应采取紧密整合的策略，将研发重点与临床证据的生成、生产韧性和商业化准备工作紧密结合。优先产生可操作的临床证据，将医疗设备属性与以患者为中心的疗效和营运效率联繫起来，并设计能够产生可操作见解的研究方案，以引起支付方和采购团队的共鸣。同时，投资多元化的供应链和区域性生产方案，以降低贸易政策变化带来的风险，并确保高频手术的短期供应可靠性。将品质源自于设计 (QbD) 原则融入开发平臺，将缩短监管核准时间，并提高不同製造地的产品一致性。

一项结合临床医生访谈、技术文献综述和供应链图谱分析的严谨混合调查方法，得出了可操作且可复製的结论。

我们的研究途径采用混合方法设计，结合了全面的文献综述、对临床专家的访谈以及供应商生态系统分析，以从技术、临床和商业性三个层面进行三角验证。主要定性资料包括对介入性心臟病专家、介入神经放射学专家、血管外科医师和采购主管的深度访谈，旨在了解他们对器械性能、手术偏好和采购驱动因素的实际观点。从这些访谈中提取的主题编码识别出反覆出现的挑战，包括实施障碍、设计权衡和证据缺口。次要研究整合了同行评审文献、监管指导文件和器械标籤，以检验技术声明并将产品性能属性与临床终点相匹配。

本文简明扼要地总结了在自动扩张型支架技术领域竞争的组织所面临的临床、技术和商业性方面的策略要务。

自膨式血管支架处于材料科学、介入技术和医疗系统经济的关键交叉领域。该技术的发展轨迹受到合金和涂层的持续改进、拓展临床应用的流程创新以及整个治疗路径中对可验证价值的商业性压力等因素的影响。希望在该领域主导的相关人员必须整合高品质的临床证据、供应链韧性以及以临床医生为中心的商业化策略，以实现可持续的应用。不断变化的监管预期和支付方日益严格的审查进一步凸显了生命週期数据和真实世界性能监测的重要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 自膨式血管支架市场（依材料分类）

  • 钴铬
  • 镍钛诺
  • 聚合物
  • 不銹钢

9. 自膨式血管支架市场（依设计划分）

  • 裸金属
  • 覆盖类型
  • 药物释放型型

10. 自膨式血管支架市场（依手术类型划分）

  • 腹部主动脉血管瘤修復
  • 颈动脉置入术
  • 股动脉置入术
  • 髂动脉置入术

第十一章 自膨式血管支架市场（按应用领域划分）

  • 冠状动脉
    • 分叉病变
    • 慢性完全闭塞
    • 支架内血管再阻塞
  • 神经血管
    • 动脉瘤
    • 预防中风
  • 外围

12. 自膨式血管支架市场（依最终用户划分）

  • 门诊手术中心
  • 心臟中心
  • 医院

13. 自膨式血管支架市场依适应症划分

  • 动脉瘤治疗
  • 动脉粥状硬化

14. 各地区自膨式血管支架市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

15. 自膨式血管支架市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各国自膨式血管支架市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

17. 美国自膨式血管支架市场

第十八章：中国自膨式血管支架市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Beijing Lepu Medical Technology Co., Ltd.
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Stryker Corporation
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-4F7A6D4FF38D

The Self-Expanding Vascular Stent Market was valued at USD 3.55 billion in 2025 and is projected to grow to USD 3.91 billion in 2026, with a CAGR of 10.09%, reaching USD 6.97 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.55 billion
Estimated Year [2026] USD 3.91 billion
Forecast Year [2032] USD 6.97 billion
CAGR (%) 10.09%

A concise clinical and commercial framing of self-expanding stent technology that situates device performance within contemporary interventional practice and stakeholder expectations

Self-expanding vascular stents have emerged as pivotal devices in the management of complex vascular pathologies, driven by material science advances and evolving clinical practices. These devices leverage shape-memory alloys and innovative polymer coatings to provide immediate vessel scaffolding while accommodating tortuous anatomies and variable vessel diameters. Clinicians increasingly prefer self-expanding designs for anatomies where radial force needs dynamic adaptation and where deployment precision must balance with long-term vessel healing. As a result, device developers and health systems are recalibrating product specifications, supply chains, and procedural protocols to reflect the distinctive mechanical and biological interactions of these implants.

The technology's maturation intersects with broader shifts in minimally invasive care, regulatory oversight, and reimbursement pathways. Manufacturers face elevated demands for biocompatibility, imaging compatibility, and long-term durability evidence, while interventional specialists press for thinner profiles, enhanced deliverability, and adjunctive drug-eluting options to reduce restenosis risk. Concurrently, supply chain resilience and quality management systems have become non-negotiable as OEMs scale production and prepare for expanded clinical indications. This introduction establishes the clinical rationale and commercial logic that underpin the subsequent analysis and sets expectations for the evidence, stakeholder behaviors, and strategic responses explored in the full report.

How converging technological advances, procedural shifts, and regulatory expectations are reshaping clinical adoption and competitive positioning for self-expanding vascular stents

The landscape for self-expanding vascular stents is experiencing transformative shifts driven by converging technological innovation, procedural evolution, and health system priorities. Advances in alloy engineering and polymer science have enabled devices with superior conformability and controlled radial strength, which in turn are influencing procedural selection and post-procedural management. Simultaneously, the rise of hybrid and image-guided interventions has expanded the role of self-expanding devices into anatomies previously considered challenging, such as complex peripheral and neurovascular territories. These developments are reshaping clinical pathways, requiring new training modules and altered inventory profiles in catheterization laboratories and surgical centers.

Payer dynamics and value-based procurement models are also prompting manufacturers to invest in evidence generation that links device attributes to measurable downstream outcomes, including reduced reinterventions and shorter hospital stays. At the same time, regulatory authorities are emphasizing real-world performance and lifecycle data, which encourages iterative design improvements and post-market surveillance investments. This combination of technological progress, procedural innovation, and regulatory evolution creates a dynamic environment where agility in clinical evidence generation and manufacturing scalability becomes a competitive differentiator.

Assessing the operational and strategic consequences of 2025 tariff developments on sourcing, manufacturing footprints, and supply continuity for implantable vascular devices

Tariff actions and trade policy adjustments in 2025 introduced a layer of complexity into global supply dynamics for medical devices, including self-expanding vascular stents. Manufacturers that rely on cross-border sourcing for raw alloys, specialized polymers, or precision manufacturing equipment faced cost re-evaluations and logistics recalibrations. Import duties and compliance checkpoints increased the administrative burden for supply chain teams, prompting some firms to consider reshoring critical production steps or to diversify supplier bases regionally. These strategic supply chain responses prioritized continuity of supply, traceability, and compliance with evolving customs regimes.

Clinicians and procurement teams experienced downstream effects through altered delivery lead times and revised inventory strategies. Health systems that operate within tightly managed capital frameworks confronted decisions about buffer stock levels and vendor consolidation to mitigate exposure to tariff volatility. In parallel, manufacturers accelerated conversations with contract manufacturers and logistics partners to negotiate terms that balance predictability with cost-efficiency. The combined impact of tariffs and trade shifts therefore underscored the importance of flexible manufacturing footprints, robust supplier qualification processes, and scenario-based sourcing strategies to preserve clinical availability while managing commercial pressures.

Layered segmentation insights that map material science, clinical application, device architecture, and care settings to prioritized product and commercialization choices

A nuanced segmentation analysis reveals where clinical needs, material science, and care delivery settings intersect to shape product strategies and commercial focus. Based on material, devices are differentiated by Cobalt-Chromium, Nitinol, Polymer, and Stainless Steel constructions-each offering distinct trade-offs in terms of radial strength, fatigue resistance, and imaging artifact profiles that influence clinical selection. Based on application, target anatomies span Coronary, Neurovascular, and Peripheral territories; the Coronary application further encompasses treatment for bifurcation lesions, chronic total occlusion, and in-stent restenosis, while Neurovascular use targets aneurysm treatment and stroke prevention, illustrating how anatomical complexity dictates design and delivery characteristics. Based on design, stents present as bare metal, covered, or drug eluting platforms, with each design class carrying implications for clinical outcomes, anticoagulation strategies, and long-term vessel remodeling.

Based on end user, procurement and utilization differ across ambulatory surgical centers, cardiac centers, and hospitals, with site-specific purchasing protocols, inventory capacities, and clinical staffing that influence product adoption. Based on indication, the primary clinical objectives bifurcate into aneurysm treatment and management of atherosclerotic disease, driving divergent evidence requirements and follow-up regimens. Based on procedure type, clinical workflows and device specifications vary across abdominal aortic aneurysm repair, carotid artery stenting, femoral artery stenting, and iliac artery stenting, each procedure category imposing unique constraints on delivery system profile, radiopacity, and navigability. Understanding these layered dimensions enables manufacturers and clinicians to align design priorities, training programs, and commercial approaches with the real-world contexts in which these devices are selected and used.

Regional strategic considerations that reconcile diverse regulatory realities, clinical practices, and procurement dynamics across the Americas, EMEA, and Asia-Pacific

Regional dynamics materially influence strategic priorities for developers and health systems. In the Americas, rapid adoption of minimally invasive interventions and established reimbursement pathways drive demand for devices that demonstrate procedural efficiency and durable outcomes. Health systems emphasize comparative effectiveness and durable clinical data to inform procurement, while centers of excellence in major urban hospitals function as early adopters for advanced designs. In Europe, Middle East & Africa, regulatory fragmentation and heterogeneous reimbursement policies create a mosaic of adoption patterns; manufacturers must balance centralized trial strategies with localized evidence generation and tailored pricing models to gain traction across diverse healthcare markets. In this region, cost sensitivity in some markets coexists with pockets of sophisticated care delivery that demand high-performance devices.

In the Asia-Pacific region, rapid expansion of interventional capacity, growing incidence of vascular disease, and investments in domestic manufacturing are reshaping competitive dynamics. Local regulatory pathways are evolving, and strategic partnerships with regional clinical leaders accelerate adoption. Across all regions, differences in clinical practice patterns, reimbursement structures, and supply chain resilience necessitate differentiated go-to-market approaches that account for regulatory timelines, local clinical champions, and procurement behaviors. Success in any region depends on harmonizing clinical evidence, operational readiness, and culturally informed engagement with key stakeholders.

Strategic competitive levers that combine clinical evidence generation, manufacturing agility, and platform licensing to establish durable differentiation in implantable vascular devices

Competitive dynamics in the self-expanding stent space are driven by the depth of clinical evidence, breadth of device portfolios, and the agility of manufacturing and regulatory capabilities. Leading firms that integrate iterative device design with robust post-market surveillance create a feedback loop that accelerates device optimization and supports differentiated clinical claims. Strategic partnerships with academic centers and high-volume clinical sites serve as incubators for novel indications and procedural refinements, while collaborations with contract manufacturers and logistics specialists enable geographic expansion without compromising quality systems. Intellectual property around alloys, coatings, and delivery mechanisms remains a core asset, and firms that protect and selectively license these technologies can expand revenue streams while managing development risk.

At the same time, competitive advantage accrues to organizations that can demonstrate reproducible clinical outcomes across diverse patient cohorts and procedural contexts. Companies that invest in clinician training, simulation platforms, and comprehensive device support systems lower adoption barriers and shorten learning curves. Finally, entrants that leverage modular platform strategies-where a common delivery system supports multiple stent types or indications-can scale more efficiently and respond to clinician feedback without protracted redevelopment cycles. These strategic levers collectively define a competitive playbook for firms seeking durable differentiation in a space characterized by rapid clinical and technological evolution.

Actionable cross-functional recommendations that synchronize clinical evidence generation, resilient manufacturing, and clinician-focused commercialization to accelerate adoption and sustain value

Industry leaders should pursue a tightly integrated strategy that aligns R&D priorities with clinical evidence generation, manufacturing resilience, and commercial readiness. Prioritize generating pragmatic clinical evidence that connects device attributes to patient-centered outcomes and operational efficiencies, and structure studies to produce actionable insights that resonate with payers and procurement teams. Concurrently, invest in diversified supply chains and regional manufacturing options to mitigate exposure to trade policy shifts and to ensure near-term delivery reliability for high-volume procedures. Embedding quality-by-design principles into development pipelines will reduce time to regulatory acceptance and improve product consistency across production sites.

Commercial organizations should adopt clinician-centered engagement programs that combine hands-on training with outcome-monitoring support to facilitate adoption in both specialty cardiac centers and ambulatory settings. Consider modular platform approaches that enable faster introduction of incremental innovations without rebuilding core delivery systems. Finally, create cross-functional capabilities that translate post-market evidence into compelling value narratives for hospital administrators and health systems, focusing on total cost of care, patient throughput advantages, and reduced reintervention burdens. This integrated approach will position leaders to capture clinical trust and to sustain commercial momentum as procedural paradigms evolve.

A rigorous mixed-methods research framework combining clinician interviews, technical literature synthesis, and supply chain mapping to produce actionable and reproducible insights

The research approach relied on a mixed-methods design that combined comprehensive literature appraisal, expert clinician interviews, and supplier ecosystem mapping to triangulate insights across technical, clinical, and commercial domains. Primary qualitative inputs included in-depth interviews with interventional cardiologists, neurointerventional specialists, vascular surgeons, and procurement leaders to capture frontline perspectives on device performance, procedural preferences, and purchasing drivers. These conversations informed thematic coding that identified recurring adoption barriers, design trade-offs, and evidence gaps. Secondary research synthesized current peer-reviewed literature, regulatory guidance documents, and device labeling to validate technical claims and to align product performance attributes with clinical endpoints.

Supply chain assessments incorporated structured reviews of manufacturing footprints, materials sourcing dependencies, and logistics constraints to evaluate operational risk points. Regulatory pathway analysis focused on the procedural and data expectations across major jurisdictions, while clinical evidence mapping highlighted where post-market studies could meaningfully de-risk adoption. The methodology emphasized transparency and reproducibility, documenting data sources, interview protocols, and analytic assumptions to enable clients to trace the evidence that supports each insight. The mixed-methods approach ensures that strategic recommendations rest on convergent evidence from practitioners, technical documentation, and operational analysis.

Concise synthesis of clinical, technical, and commercial imperatives that define the strategic path for organizations competing in self-expanding stent technologies

Self-expanding vascular stents occupy a pivotal intersection of material science, interventional technique, and health system economics. The technology's trajectory is shaped by continuous improvements in alloys and coatings, by procedural innovations that expand clinical applications, and by commercial pressures that demand demonstrable value across care pathways. Stakeholders seeking to lead in this space must integrate high-quality clinical evidence, supply chain resilience, and clinician-centered commercialization to build durable adoption. The evolution of regulatory expectations and payer scrutiny further elevates the importance of lifecycle data and real-world performance monitoring.

In sum, the pathway to sustained success requires coordinated investments across product development, evidence generation, manufacturing operations, and market access. Organizations that align these components with clearly articulated clinical and economic narratives will find the greatest opportunities to differentiate, to support clinician confidence, and to deliver patient-centered outcomes. The subsequent full report expands on these themes with detailed clinical profiles, device-level comparisons, procedural workflow implications, and a prioritized set of strategic initiatives designed to guide decision makers through near- and medium-term choices.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Self-Expanding Vascular Stent Market, by Material

  • 8.1. Cobalt-Chromium
  • 8.2. Nitinol
  • 8.3. Polymer
  • 8.4. Stainless Steel

9. Self-Expanding Vascular Stent Market, by Design

  • 9.1. Bare Metal
  • 9.2. Covered
  • 9.3. Drug Eluting

10. Self-Expanding Vascular Stent Market, by Procedure Type

  • 10.1. Abdominal Aortic Aneurysm Repair
  • 10.2. Carotid Artery Stenting
  • 10.3. Femoral Artery Stenting
  • 10.4. Iliac Artery Stenting

11. Self-Expanding Vascular Stent Market, by Application

  • 11.1. Coronary
    • 11.1.1. Bifurcation Lesions
    • 11.1.2. Chronic Total Occlusion
    • 11.1.3. In-Stent Restenosis
  • 11.2. Neurovascular
    • 11.2.1. Aneurysm
    • 11.2.2. Stroke Prevention
  • 11.3. Peripheral

12. Self-Expanding Vascular Stent Market, by End User

  • 12.1. Ambulatory Surgical Center
  • 12.2. Cardiac Center
  • 12.3. Hospital

13. Self-Expanding Vascular Stent Market, by Indication

  • 13.1. Aneurysm Treatment
  • 13.2. Atherosclerosis

14. Self-Expanding Vascular Stent Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Self-Expanding Vascular Stent Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Self-Expanding Vascular Stent Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Self-Expanding Vascular Stent Market

18. China Self-Expanding Vascular Stent Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. B. Braun Melsungen AG
  • 19.7. Becton, Dickinson and Company
  • 19.8. Beijing Lepu Medical Technology Co., Ltd.
  • 19.9. Boston Scientific Corporation
  • 19.10. Cook Group Incorporated
  • 19.11. Medtronic plc
  • 19.12. Meril Life Sciences Pvt. Ltd.
  • 19.13. MicroPort Scientific Corporation
  • 19.14. Stryker Corporation
  • 19.15. Terumo Corporation
  • 19.16. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COBALT-CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COBALT-CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COBALT-CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY BARE METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY BARE METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY BARE METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COVERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COVERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COVERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DRUG ELUTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DRUG ELUTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DRUG ELUTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CAROTID ARTERY STENTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CAROTID ARTERY STENTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CAROTID ARTERY STENTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY FEMORAL ARTERY STENTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY FEMORAL ARTERY STENTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY FEMORAL ARTERY STENTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ILIAC ARTERY STENTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ILIAC ARTERY STENTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ILIAC ARTERY STENTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY BIFURCATION LESIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY BIFURCATION LESIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY BIFURCATION LESIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY IN-STENT RESTENOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY IN-STENT RESTENOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY IN-STENT RESTENOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY STROKE PREVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY STROKE PREVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY STROKE PREVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CARDIAC CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CARDIAC CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CARDIAC CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ANEURYSM TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ANEURYSM TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ANEURYSM TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ATHEROSCLEROSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ATHEROSCLEROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 165. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 168. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 171. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 172. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 192. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 194. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 195. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 198. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 199. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 201. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 203. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 204. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 207. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 208. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)